KOOL - Cesca Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.4248
-0.1152 (-7.4805%)
As of 12:43PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.5400
Open1.6100
Bid1.4100 x 2800
Ask1.4300 x 3000
Day's Range1.4100 - 1.6100
52 Week Range1.4100 - 6.4400
Volume83,275
Avg. Volume81,224
Market Cap16.36M
Beta0.48
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Has Cesca Therapeutics Inc (NASDAQ:KOOL) Improved Earnings Growth In Recent Times?
    Simply Wall St.8 days ago

    Has Cesca Therapeutics Inc (NASDAQ:KOOL) Improved Earnings Growth In Recent Times?

    When Cesca Therapeutics Inc (NASDAQ:KOOL) announced its most recent earnings (31 December 2017), I did two things: looked at its past earnings track record, then look at what is happeningRead More...

  • Cesca raising $1.4 million in direct offering of stock
    American City Business Journalslast month

    Cesca raising $1.4 million in direct offering of stock

    Cesca Therapeutics Inc., a Rancho Cordova-based developer of regenerative medical technology, is raising $1.4 million in a direct offering of stock to institutional investors.

  • Cesca Therapeutics Inc (NASDAQ:KOOL) And The Healthcare Industry Prospect For 2018
    Simply Wall St.2 months ago

    Cesca Therapeutics Inc (NASDAQ:KOOL) And The Healthcare Industry Prospect For 2018

    Cesca Therapeutics Inc (NASDAQ:KOOL), a US$29.36M small-cap, is a healthcare company operating in an industry, which faces key trends such as rising demand fuelled by an aging population and theRead More...

  • Why Cesca Therapeutics Inc’s (NASDAQ:KOOL) Investor Composition Impacts Your Returns
    Simply Wall St.4 months ago

    Why Cesca Therapeutics Inc’s (NASDAQ:KOOL) Investor Composition Impacts Your Returns

    Today, I will be analyzing Cesca Therapeutics Inc’s (NASDAQ:KOOL) recent ownership structure, an important but not-so-popular subject among individual investors. The impact of a company’s ownership structure affects both itsRead More...

  • Where Cesca Therapeutics Inc (NASDAQ:KOOL) Stands In Terms Of Earnings Growth Against Its Industry
    Simply Wall St.4 months ago

    Where Cesca Therapeutics Inc (NASDAQ:KOOL) Stands In Terms Of Earnings Growth Against Its Industry

    For long term investors, improvement in profitability and outperformance against the industry can be important characteristics in a stock. In this article, I will take a look at Cesca TherapeuticsRead More...

  • Capital Cube4 months ago

    ETFs with exposure to Cesca Therapeutics, Inc. : December 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cesca Therapeutics, Inc. Here are 5 ETFs with the largest exposure to KOOL-US. Comparing the performance and risk of Cesca Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: Q1, 2018 By the Numbers : December 26, 2017
    Capital Cube4 months ago

    Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: Q1, 2018 By the Numbers : December 26, 2017

    Categories: Yahoo FinanceGet free summary analysis Cesca Therapeutics, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Cesca Therapeutics, Inc. – Kewaunee Scientific Corporation, Cerus Corporation, Haemonetics Corporation and Cytori Therapeutics, Inc. (KEQU-US, CERS-US, HAE-US and CYTX-US) that have also reported for this period. Highlights ... Read more (Read more...)

  • How Financially Strong Is Cesca Therapeutics Inc (KOOL)?
    Simply Wall St.5 months ago

    How Financially Strong Is Cesca Therapeutics Inc (KOOL)?

    Cesca Therapeutics Inc (NASDAQ:KOOL) is a small-cap stock with a market capitalization of $29.99M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, theyRead More...

  • Capital Cube5 months ago

    ETFs with exposure to Cesca Therapeutics, Inc. : December 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cesca Therapeutics, Inc. Here are 5 ETFs with the largest exposure to KOOL-US. Comparing the performance and risk of Cesca Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • American City Business Journals5 months ago

    Cesca Therapeutics aims to raise nearly $3 million with share offering

    Cesca Therapeutics Inc., a Rancho Cordova-based developer of regenerative medicine technology, announced a public share offering that aims to raise $2.7 million through the sale of 900,000 shares at $3 per share. The gross proceeds from the offering are expected to be $2.7 million, with $2.3 million going to Cesca (KOOL) after the placement agent’s commission and other expenses. Dawson James Securities Inc. is serving as the placement agent for the offering.

  • Capital Cube7 months ago

    ETFs with exposure to Cesca Therapeutics, Inc. : September 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cesca Therapeutics, Inc. Here are 5 ETFs with the largest exposure to KOOL-US. Comparing the performance and risk of Cesca Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: 2017 By the Numbers : September 25, 2017
    Capital Cube7 months ago

    Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: 2017 By the Numbers : September 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Cesca Therapeutics, Inc. reports financial results for the year ended June 30, 2017. We analyze the earnings along side the following peers of Cesca Therapeutics, Inc. – Kewaunee Scientific Corporation, Cerus Corporation, Stryker Corporation, Haemonetics Corporation and Cytori Therapeutics, Inc. (KEQU-US, CERS-US, SYK-US, HAE-US and CYTX-US) that have also reported for ... Read more (Read more...)

  • GuruFocus.com7 months ago

    Cesca Therapeutics Inc (KOOL) Files 10-K for the Fiscal Year Ended on June 30, 2017

    Cesca Therapeutics Inc (NASDAQ:KOOL) files its latest 10-K with SEC for the fiscal year ended on June 30, 2017.

  • TheStreet.com9 months ago

    Biotech Movers: Cesca Up Strong After Securing CAR-T Cell Patent

    And a management shakeup helps push down NuVasive.

  • Zacks9 months ago

    Company News for July 11, 2017

    Companies in the News are: HCOM,CBB,KOOL,MYCC,APO,CETV